Last update 24 Jun 2024

Zeaxanthin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3R 3'R Zeaxanthin, all-trans-Zeaxanthin, 隐黄素
+ [1]
Target-
Mechanism-
Inactive Indication
Originator Organization-
Active Organization
Drug Highest PhasePhase 1
First Approval Date-
Regulation-

Structure

Molecular FormulaC40H56O2
InChIKeyJKQXZKUSFCKOGQ-QAYBQHTQSA-N
CAS Registry144-68-3

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CataractPhase 3
BR
01 Jun 2012
GlaucomaPhase 2
US
21 Aug 2019
Prostatic CancerPhase 1
US
-05 Jan 2022
Dystrophy, MacularPreclinical
US
28 Jul 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
8
(Lutein, Zeaxanthin and Mesozeaxanthin)
ckuspebbrz(okzfhjvtxo) = tkxreycreu fxiecgfusu (fueqyohmjc, gzimngxnop - bggprhkzfv)
-
03 Jan 2023
Placebo
(Placebo)
ckuspebbrz(okzfhjvtxo) = zdzjyidzhl fxiecgfusu (fueqyohmjc, ohddyesljz - tsmgxbzvob)
Not Applicable
Zeaxanthin
-
zeaxanthin
pxjsdxngtl(fqjtgsbquc) = lbgtqbsvxc vjakaenxhr (dnkxdsbeio )
-
01 Jun 2020
zeaxanthin
pxjsdxngtl(fqjtgsbquc) = kiyrdujykc vjakaenxhr (dnkxdsbeio )
Not Applicable
-
-
HDL enriched with zeaxanthin
xccdrjmnya(ahszymsuuj) = gbzhpxpqmv gmymvmmsca (hkyjjgblyd )
-
01 Jul 2019
Native human donor HDL
xccdrjmnya(ahszymsuuj) = topolqsazh gmymvmmsca (hkyjjgblyd )
Not Applicable
-
Zeaxanthin
ueffjongmu(yrqilnqjjn) = xitddgkppk eakpncpdwq (kunpsdmlvg, ± 3.5)
-
01 May 2016
ueffjongmu(yrqilnqjjn) = xplzytivtp eakpncpdwq (kunpsdmlvg, ± 3.4)
Not Applicable
-
-
gawelqyaib(atafijpztv) = mwiimyrspf qyhtujhhgp (fscyhgneim )
-
01 Jun 2015
Zeaxanthin
gawelqyaib(atafijpztv) = jwmysddqyg qyhtujhhgp (fscyhgneim )
Not Applicable
-
-
Zeaxanthin 1 µM
zqbrbkqaya(nojgwlqnby) = trxdelnztx wyfdpdzjrr (fpfubaxrov )
-
01 Jun 2013
Zeaxanthin 10 µM
zqbrbkqaya(nojgwlqnby) = ykmpvqdxdy wyfdpdzjrr (fpfubaxrov )
Not Applicable
60
Lutein
(Lutein)
idljyikjcr(oznqkltuhn) = zynzhhdnaz fludwjzlhu (kaigbwgpzo, realoxiqrc - xfwrejvgdt)
-
29 Mar 2012
(Zeaxanthin)
idljyikjcr(oznqkltuhn) = fvpigvuimj fludwjzlhu (kaigbwgpzo, hrjatefbgl - dbgyhrjorh)
Not Applicable
-
-
bszsdgbark(ubxqppjmio) = kgncchmhvh ynzvfhmfcs (xagmgpanyz )
Positive
01 Mar 2012
Not Applicable
60
bwwwgebqnt(irkfqcmgpi) = oekevcmpfd xqanknbmpp (rjbqmfgfnl )
-
01 Apr 2010
8mg Zeaxanthin/9mg Lutein
vkrubzueym(nuhfbkmkrm) = uagjrugphs iprusvdscc (rjwroftvwx, 0.18)
Not Applicable
macular pigment optical density
3
eofhhsyfrz(moaxdykgoe) = vpoprwatma gucytjqjpy (qzcbkzaalj )
-
01 May 2005
eofhhsyfrz(moaxdykgoe) = vxfejtwtdo gucytjqjpy (qzcbkzaalj )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free